Structure and organization of drug-target networks: insights from genomic approaches for drug discovery.

Abstract

Recent years have seen an explosion in the amount of "omics" data and the integration of several disciplines, which has influenced all areas of life sciences including that of drug discovery. Several lines of evidence now suggest that the traditional notion of "one drug-one protein" for one disease does not hold any more and that treatment for most complex diseases can best be attempted using polypharmacological approaches. In this review, we formalize the definition of a drug-target network by decomposing it into drug, target and disease spaces and provide an overview of our understanding in recent years about its structure and organizational principles. We discuss advances made in developing promiscuous drugs following the paradigm of polypharmacology and reveal their advantages over traditional drugs for targeting diseases such as cancer. We suggest that drug-target networks can be decomposed to be studied at a variety of levels and argue that such network-based approaches have important implications in understanding disease phenotypes and in accelerating drug discovery. We also discuss the potential and scope network pharmacology promises in harnessing the vast amount of data from high-throughput approaches for therapeutic advantage.

DOI: 10.1039/B908147j

6 Figures and Tables

05010020102011201220132014201520162017
Citations per Year

178 Citations

Semantic Scholar estimates that this publication has 178 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Janga2009StructureAO, title={Structure and organization of drug-target networks: insights from genomic approaches for drug discovery.}, author={Sarath Chandra Janga and Andreas G. Tzakos}, journal={Molecular bioSystems}, year={2009}, volume={5 12}, pages={1536-48} }